Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00115947
Status:
COMPLETED
Last Update Posted:
2006-03-09
First Post:
2005-06-26
Brief Title:
Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites
Sponsor:
Hvidovre University Hospital
Organization:
Hvidovre University Hospital
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2005-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the effect of terlipressin on myocardial perfusion and renal function
Hypothesis Significant improvement of renal function reflected by glomerular filtration rate GFR renal blood flow RBF excretion of salt and metabolites in the urine and related hormones and peptides in the blood No effect on the systolic function of the heart
Hypothesis Significant improvement of renal function reflected by glomerular filtration rate GFR renal blood flow RBF excretion of salt and metabolites in the urine and related hormones and peptides in the blood No effect on the systolic function of the heart
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None